ImmunityBio Secures Exclusive U.S. Rights to Bacillus Calmette-Guérin (BCG) Treatment for Bladder Cancer from Japan BCG Laboratory
ImmunityBio (IBRX), a San Diego, California-based biotechnology company, announced on Saturday a significant licensing agreement to acquire exclusive U.S. rights for Bacillus Calmette-Guérin (BCG) treatment, a critical therapy for bladder…
